Le Wang
Impact in
- Hepatology top 2%
- Liver Disease and Transplantation
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Hepatology 22
- Liver Disease and Transplantation 18
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Surgery 34
- Coronary Interventions and Diagnostics 6
- Pancreatic function and diabetes 5
- Helicobacter pylori-related gastroenterology studies 4
- Co-authors
- Xingshun Qi (29 shared papers)Hongliang Cong (12 shared papers)Ao Wei (5 shared papers)Jingxia Zhang (6 shared papers)Yuecheng Hu (8 shared papers)Sheng Bi (3 shared papers)Wei Qi (4 shared papers)Libin Ren (2 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (4 papers)Frontiers in Oncology (3 papers)Neurological Sciences (3 papers)Advances in Therapy (2 papers)Cardiovascular Diabetology (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Le Wang
147 papers receiving 2.2k citations
Le Wang's Hit Papers
Peers
Comparison fields: 5 of 93
- Hepatology 303
- Endocrinology, Diabetes and Metabolism 195
- Pathology and Forensic Medicine 133
- Surgery 273
- Internal Medicine 20
Countries citing papers authored by Le Wang
This map shows the geographic impact of Le Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Wang more than expected).
Fields of papers citing papers by Le Wang
This network shows the impact of papers produced by Le Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Wang. The network helps show where Le Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Le Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome Hit paper breakdown → | 2020 | 284 |
| 2 | 2014 | 107 | |
| 3 | 2015 | 75 | |
| 4 | 2014 | 69 | |
| 5 | 2014 | 65 | |
| 6 | 2018 | 63 | |
| 7 | 2014 | 57 | |
| 8 | 2022 | 56 | |
| 9 | 2020 | 54 | |
| 10 | 2024 | 45 | |
| 11 | 2018 | 43 | |
| 12 | 2016 | 39 | |
| 13 | 2022 | 37 | |
| 14 | 2021 | 35 | |
| 15 | 2017 | 30 | |
| 16 | 2019 | 30 | |
| 17 | 2021 | 30 | |
| 18 | 2024 | 30 | |
| 19 | 2020 | 25 | |
| 20 | 2021 | 24 |
About Le Wang
Le Wang is a scholar working on Hepatology, Surgery, Pathology and Forensic Medicine, Gastroenterology and Endocrinology, Diabetes and Metabolism, having authored 155 papers that have together received 2.2k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (18 papers), Coronary Interventions and Diagnostics (6 papers), Pancreatic function and diabetes (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Obstructive Sleep Apnea Research (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Hepatology (303 citations), Endocrinology, Diabetes and Metabolism (195 citations), Pathology and Forensic Medicine (133 citations), Surgery (273 citations) and Internal Medicine (20 citations). Le Wang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Xingshun Qi, Hongliang Cong, Ao Wei, Jingxia Zhang, Yuecheng Hu, Sheng Bi, Wei Qi, Libin Ren, Wenyu Li and Xiaozhong Guo. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Frontiers in Oncology, Neurological Sciences, Advances in Therapy and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.